Nasdaq Eton News Today

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) saw a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 954,600 shares, a decline of 5.5% from the October 15th total of 1,010,000 shares. Currently, 4.3% of the company’s shares are short sold. Based on an […]

Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) shot up 4.5% during trading on Monday . The stock traded as high as $3.95 and last traded at $3.91. 87,825 shares changed hands during trading, a decline of 52% from the average session volume of 183,452 shares. The stock had previously closed at $3.74. […]

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) and Creative Edge Nutrition (OTCMKTS:FITX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Institutional & Insider Ownership 23.3% of Eton […]

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) saw a large drop in short interest in the month of August. As of August 31st, there was short interest totalling 958,600 shares, a drop of 27.4% from the August 15th total of 1,320,000 shares. Based on an average daily trading volume, of 413,400 shares, the short-interest […]

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) and Planet 13 (OTCMKTS:PLNHF – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Profitability This table compares Eton Pharmaceuticals and Planet […]

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) was the recipient of a significant increase in short interest in August. As of August 15th, there was short interest totalling 1,320,000 shares, an increase of 150.1% from the July 31st total of 527,700 shares. Currently, 5.9% of the shares of the stock are sold short. Based […]

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) is set to release its earnings data after the market closes on Thursday, August 10th. Analysts expect Eton Pharmaceuticals to post earnings of ($0.09) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Eton Pharmaceuticals […]

Eton Pharmaceuticals (NASDAQ:ETON – Free Report) had its price objective trimmed by HC Wainwright from $10.00 to $9.00 in a research note issued to investors on Monday, The Fly reports. HC Wainwright also issued estimates for Eton Pharmaceuticals’ Q2 2024 earnings at $0.02 EPS, Q3 2024 earnings at $0.03 EPS, Q4 2024 earnings at $0.06 […]

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 530,400 shares, a decline of 9.7% from the April 30th total of 587,500 shares. Approximately 2.4% of the shares of the stock are sold short. Based on […]

Opaleye Management Inc. lowered its stake in shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Rating) by 13.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,170,000 shares of the company’s stock after selling 351,000 shares during the quarter. Eton Pharmaceuticals […]